Anti-obesity Medication Market (2024 - 2030) Size, Share & Trends Analysis Report By Product (Approved, Off-label), By Mechanism Of Action (Peripherally Acting Drugs, Centrally Acting Drugs), By Distribution Channel, By Region, And Segment Forecasts

Market Segmentation

• Anti-Obesity Medication Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Approved
    • Bupropion-naltrexone (Contrave)
    • Liraglutide (Orlistat)
    • Orlistat
      • Xenical
      • Alli
    • Phentermine-topiramate (Qsymia)
    • Semaglutide (Wegovy)
    • Setmelanotide (Imcivree)
    • Tirzepatide (Zepbound)
  • Off Label
    • Semaglutide (Xenical Alli)
    • Liraglutide (Semaglutide (Wegovy))
    • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
    • Others
• Anti-Obesity Medication Mechanism of Action Outlook (Revenue, USD Million, 2018 - 2030)
  • Peripherally Acting Drugs
  • Centrally Acting Drugs
• Anti-Obesity Medication Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
  • Retail Pharmacies
  • Hospital Pharmacies
  • Others
• Anti-Obesity Medication Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • North America Anti-Obesity Medication Market, By Product
      • Approved
        • Bupropion-naltrexone (Contrave)
        • Liraglutide (Orlistat)
        • Orlistat
          • Xenical
          • Alli
        • Phentermine-topiramate (Qsymia)
        • Semaglutide (Wegovy)
        • Setmelanotide (Imcivree)
        • Tirzepatide (Zepbound)
      • Off Label
        • Semaglutide (Xenical Alli)
        • Liraglutide (Semaglutide (Wegovy))
        • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
        • Others
      • Others
    • North America Anti-Obesity Medication Market, By Mechanism of Action
      • Peripherally Acting Drugs
      • Centrally Acting Drugs
    • North America Anti-Obesity Medication Market, By Distribution Channel
      • Retail Pharmacies
      • Hospital Pharmacies
      • Others
    • U.S.
      • U.S. Anti-Obesity Medication Market, By Product
        • Approved
          • Bupropion-naltrexone (Contrave)
          • Liraglutide (Orlistat)
          • Orlistat
            • Xenical
            • Alli
          • Phentermine-topiramate (Qsymia)
          • Semaglutide (Wegovy)
          • Setmelanotide (Imcivree)
          • Tirzepatide (Zepbound)
        • Off Label
          • Semaglutide (Xenical Alli)
          • Liraglutide (Semaglutide (Wegovy))
          • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
          • Others
      • U.S. Anti-Obesity Medication Market, By Mechanism of Action
      • Peripherally Acting Drugs
      • Centrally Acting Drugs
      • U.S. Anti-Obesity Medication Market, By Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • Others
    • Canada
      • Canada Anti-Obesity Medication Market, By Product
        • Approved
          • Bupropion-naltrexone (Contrave)
          • Liraglutide (Orlistat)
          • Orlistat
            • Xenical
            • Alli
          • Phentermine-topiramate (Qsymia)
          • Semaglutide (Wegovy)
          • Setmelanotide (Imcivree)
          • Tirzepatide (Zepbound)
        • Off Label
          • Semaglutide (Xenical Alli)
          • Liraglutide (Semaglutide (Wegovy))
          • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
          • Others
      • Canada Anti-Obesity Medication Market, By Mechanism of Action
      • Peripherally Acting Drugs
      • Centrally Acting Drugs
      • Canada Anti-Obesity Medication Market, By Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • Others
  • Europe
    • Europe Anti-Obesity Medication Market, By Product
      • Approved
        • Bupropion-naltrexone (Contrave)
        • Liraglutide (Orlistat)
        • Orlistat
          • Xenical
          • Alli
        • Phentermine-topiramate (Qsymia)
        • Semaglutide (Wegovy)
        • Setmelanotide (Imcivree)
        • Tirzepatide (Zepbound)
      • Off Label
        • Semaglutide (Xenical Alli)
        • Liraglutide (Semaglutide (Wegovy))
        • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
        • Others
      • Others
    • Europe Anti-Obesity Medication Market, By Mechanism of Action
      • Peripherally Acting Drugs
      • Centrally Acting Drugs
    • Europe Anti-Obesity Medication Market, By Distribution Channel
      • Retail Pharmacies
      • Hospital Pharmacies
      • Others
    • UK
      • UK Anti-Obesity Medication Market, By Product
        • Approved
          • Bupropion-naltrexone (Contrave)
          • Liraglutide (Orlistat)
          • Orlistat
            • Xenical
            • Alli
          • Phentermine-topiramate (Qsymia)
          • Semaglutide (Wegovy)
          • Setmelanotide (Imcivree)
          • Tirzepatide (Zepbound)
        • Off Label
          • Semaglutide (Xenical Alli)
          • Liraglutide (Semaglutide (Wegovy))
          • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
          • Others
      • UK Anti-Obesity Medication Market, By Mechanism of Action
      • Peripherally Acting Drugs
      • Centrally Acting Drugs
      • UK Anti-Obesity Medication Market, By Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • Others
    • Germany
      • Germany Anti-Obesity Medication Market, By Product
        • Approved
          • Bupropion-naltrexone (Contrave)
          • Liraglutide (Orlistat)
          • Orlistat
            • Xenical
            • Alli
          • Phentermine-topiramate (Qsymia)
          • Semaglutide (Wegovy)
          • Setmelanotide (Imcivree)
          • Tirzepatide (Zepbound)
        • Off Label
          • Semaglutide (Xenical Alli)
          • Liraglutide (Semaglutide (Wegovy))
          • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
          • Others
      • Germany Anti-Obesity Medication Market, By Mechanism of Action
      • Peripherally Acting Drugs
      • Centrally Acting Drugs
      • Germany Anti-Obesity Medication Market, By Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • Others
    • Spain
      • Spain Anti-Obesity Medication Market, By Product
        • Approved
          • Bupropion-naltrexone (Contrave)
          • Liraglutide (Orlistat)
          • Orlistat
            • Xenical
            • Alli
          • Phentermine-topiramate (Qsymia)
          • Semaglutide (Wegovy)
          • Setmelanotide (Imcivree)
          • Tirzepatide (Zepbound)
        • Off Label
          • Semaglutide (Xenical Alli)
          • Liraglutide (Semaglutide (Wegovy))
          • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
          • Others
      • Spain Anti-Obesity Medication Market, By Mechanism of Action
      • Peripherally Acting Drugs
      • Centrally Acting Drugs
      • Spain Anti-Obesity Medication Market, By Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • Others
    • France
      • France Anti-Obesity Medication Market, By Product
        • Approved
          • Bupropion-naltrexone (Contrave)
          • Liraglutide (Orlistat)
          • Orlistat
            • Xenical
            • Alli
          • Phentermine-topiramate (Qsymia)
          • Semaglutide (Wegovy)
          • Setmelanotide (Imcivree)
          • Tirzepatide (Zepbound)
        • Off Label
          • Semaglutide (Xenical Alli)
          • Liraglutide (Semaglutide (Wegovy))
          • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
          • Others
      • France Anti-Obesity Medication Market, By Mechanism of Action
      • Peripherally Acting Drugs
      • Centrally Acting Drugs
      • France Anti-Obesity Medication Market, By Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • Others
    • Italy
      • Italy Anti-Obesity Medication Market, By Product
        • Approved
          • Bupropion-naltrexone (Contrave)
          • Liraglutide (Orlistat)
          • Orlistat
            • Xenical
            • Alli
          • Phentermine-topiramate (Qsymia)
          • Semaglutide (Wegovy)
          • Setmelanotide (Imcivree)
          • Tirzepatide (Zepbound)
        • Off Label
          • Semaglutide (Xenical Alli)
          • Liraglutide (Semaglutide (Wegovy))
          • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
          • Others
      • Italy Anti-Obesity Medication Market, By Mechanism of Action
        • Peripherally Acting Drugs
        • Centrally Acting Drugs
      • Italy Anti-Obesity Medication Market, By Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • Others
    • Denmark
      • Denmark Anti-Obesity Medication Market, By Product
        • Approved
          • Bupropion-naltrexone (Contrave)
          • Liraglutide (Orlistat)
          • Orlistat
            • Xenical
            • Alli
          • Phentermine-topiramate (Qsymia)
          • Semaglutide (Wegovy)
          • Setmelanotide (Imcivree)
          • Tirzepatide (Zepbound)
        • Off Label
          • Semaglutide (Xenical Alli)
          • Liraglutide (Semaglutide (Wegovy))
          • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
          • Others
      • Denmark Anti-Obesity Medication Market, By Mechanism of Action
      • Peripherally Acting Drugs
      • Centrally Acting Drugs
      • Denmark Anti-Obesity Medication Market, By Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • Others
    • Sweden
      • Sweden Anti-Obesity Medication Market, By Product
        • Approved
          • Bupropion-naltrexone (Contrave)
          • Liraglutide (Orlistat)
          • Orlistat
            • Xenical
            • Alli
          • Phentermine-topiramate (Qsymia)
          • Semaglutide (Wegovy)
          • Setmelanotide (Imcivree)
          • Tirzepatide (Zepbound)
        • Off Label
          • Semaglutide (Xenical Alli)
          • Liraglutide (Semaglutide (Wegovy))
          • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
          • Others
      • Sweden Anti-Obesity Medication Market, By Mechanism of Action
      • Peripherally Acting Drugs
      • Centrally Acting Drugs
      • Sweden Anti-Obesity Medication Market, By Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • Others
    • Norway
      • Norway Anti-Obesity Medication Market, By Product
        • Approved
          • Bupropion-naltrexone (Contrave)
          • Liraglutide (Orlistat)
          • Orlistat
            • Xenical
            • Alli
          • Phentermine-topiramate (Qsymia)
          • Semaglutide (Wegovy)
          • Setmelanotide (Imcivree)
          • Tirzepatide (Zepbound)
        • Off Label
          • Semaglutide (Xenical Alli)
          • Liraglutide (Semaglutide (Wegovy))
          • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
          • Others
      • Norway Anti-Obesity Medication Market, By Mechanism of Action
      • Peripherally Acting Drugs
      • Centrally Acting Drugs
      • Norway Anti-Obesity Medication Market, By Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • Others
  • Asia Pacific
    • Asia Pacific Anti-Obesity Medication Market, By Product
      • Approved
        • Bupropion-naltrexone (Contrave)
        • Liraglutide (Orlistat)
        • Orlistat
          • Xenical
          • Alli
        • Phentermine-topiramate (Qsymia)
        • Semaglutide (Wegovy)
        • Setmelanotide (Imcivree)
        • Tirzepatide (Zepbound)
      • Off Label
        • Semaglutide (Xenical Alli)
        • Liraglutide (Semaglutide (Wegovy))
        • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
        • Others
    • Asia Pacific Anti-Obesity Medication Market, By Mechanism of Action
    • Peripherally Acting Drugs
    • Centrally Acting Drugs
    • Asia Pacific Anti-Obesity Medication Market, By Distribution Channel
      • Retail Pharmacies
      • Hospital Pharmacies
      • Others
    • Japan
      • Japan Anti-Obesity Medication Market, By Product
        • Approved
          • Bupropion-naltrexone (Contrave)
          • Liraglutide (Orlistat)
          • Orlistat
            • Xenical
            • Alli
          • Phentermine-topiramate (Qsymia)
          • Semaglutide (Wegovy)
          • Setmelanotide (Imcivree)
          • Tirzepatide (Zepbound)
        • Off Label
          • Semaglutide (Xenical Alli)
          • Liraglutide (Semaglutide (Wegovy))
          • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
          • Others
      • Japan Anti-Obesity Medication Market, By Mechanism of Action
      • Peripherally Acting Drugs
      • Centrally Acting Drugs
      • Japan Anti-Obesity Medication Market, By Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • Others
    • China
      • China Anti-Obesity Medication Market, By Product
        • Approved
          • Bupropion-naltrexone (Contrave)
          • Liraglutide (Orlistat)
          • Orlistat
            • Xenical
            • Alli
          • Phentermine-topiramate (Qsymia)
          • Semaglutide (Wegovy)
          • Setmelanotide (Imcivree)
          • Tirzepatide (Zepbound)
        • Off Label
          • Semaglutide (Xenical Alli)
          • Liraglutide (Semaglutide (Wegovy))
          • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
          • Others
      • China Anti-Obesity Medication Market, By Mechanism of Action
      • Peripherally Acting Drugs
      • Centrally Acting Drugs
      • China Anti-Obesity Medication Market, By Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • Others
    • India
      • India Anti-Obesity Medication Market, By Product
        • Approved
          • Bupropion-naltrexone (Contrave)
          • Liraglutide (Orlistat)
          • Orlistat
            • Xenical
            • Alli
          • Phentermine-topiramate (Qsymia)
          • Semaglutide (Wegovy)
          • Setmelanotide (Imcivree)
          • Tirzepatide (Zepbound)
        • Off Label
          • Semaglutide (Xenical Alli)
          • Liraglutide (Semaglutide (Wegovy))
          • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
          • Others
      • India Anti-Obesity Medication Market, By Mechanism of Action
      • Peripherally Acting Drugs
      • Centrally Acting Drugs
      • India Anti-Obesity Medication Market, By Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • Others
    • Australia
      • Australia Anti-Obesity Medication Market, By Product
        • Approved
          • Bupropion-naltrexone (Contrave)
          • Liraglutide (Orlistat)
          • Orlistat
            • Xenical
            • Alli
          • Phentermine-topiramate (Qsymia)
          • Semaglutide (Wegovy)
          • Setmelanotide (Imcivree)
          • Tirzepatide (Zepbound)
        • Off Label
          • Semaglutide (Xenical Alli)
          • Liraglutide (Semaglutide (Wegovy))
          • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
          • Others
      • Australia Anti-Obesity Medication Market, By Mechanism of Action
      • Peripherally Acting Drugs
      • Centrally Acting Drugs
      • Australia Anti-Obesity Medication Market, By Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • Others
    • Thailand
      • Thailand Anti-Obesity Medication Market, By Product
        • Approved
          • Bupropion-naltrexone (Contrave)
          • Liraglutide (Orlistat)
          • Orlistat
            • Xenical
            • Alli
          • Phentermine-topiramate (Qsymia)
          • Semaglutide (Wegovy)
          • Setmelanotide (Imcivree)
          • Tirzepatide (Zepbound)
        • Off Label
          • Semaglutide (Xenical Alli)
          • Liraglutide (Semaglutide (Wegovy))
          • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
          • Others
      • Thailand Anti-Obesity Medication Market, By Mechanism of Action
      • Peripherally Acting Drugs
      • Centrally Acting Drugs
      • Thailand Anti-Obesity Medication Market, By Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • Others
    • South Korea
      • South Korea Anti-Obesity Medication Market, By Product
        • Approved
          • Bupropion-naltrexone (Contrave)
          • Liraglutide (Orlistat)
          • Orlistat
            • Xenical
            • Alli
          • Phentermine-topiramate (Qsymia)
          • Semaglutide (Wegovy)
          • Setmelanotide (Imcivree)
          • Tirzepatide (Zepbound)
        • Off Label
          • Semaglutide (Xenical Alli)
          • Liraglutide (Semaglutide (Wegovy))
          • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
          • Others
      • South Korea Anti-Obesity Medication Market, By Mechanism of Action
      • Peripherally Acting Drugs
      • Centrally Acting Drugs
      • South Korea Anti-Obesity Medication Market, By Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • Others
    • Latin America
      • Latin America Anti-Obesity Medication Market, By Product
        • Approved
          • Bupropion-naltrexone (Contrave)
          • Liraglutide (Orlistat)
          • Orlistat
            • Xenical
            • Alli
          • Phentermine-topiramate (Qsymia)
          • Semaglutide (Wegovy)
          • Setmelanotide (Imcivree)
          • Tirzepatide (Zepbound)
        • Off Label
          • Semaglutide (Xenical Alli)
          • Liraglutide (Semaglutide (Wegovy))
          • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
          • Others
      • Latin America Anti-Obesity Medication Market, By Mechanism of Action
      • Peripherally Acting Drugs
      • Centrally Acting Drugs
      • Latin America Anti-Obesity Medication Market, By Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • Others
      • Brazil
        • Brazil Anti-Obesity Medication Market, By Product
          • Approved
            • Bupropion-naltrexone (Contrave)
            • Liraglutide (Orlistat)
            • Orlistat
              • Xenical
              • Alli
            • Phentermine-topiramate (Qsymia)
            • Semaglutide (Wegovy)
            • Setmelanotide (Imcivree)
            • Tirzepatide (Zepbound)
          • Off Label
            • Semaglutide (Xenical Alli)
            • Liraglutide (Semaglutide (Wegovy))
            • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
            • Others
        • BrazilAnti-Obesity Medication Market, By Mechanism of Action
        • Peripherally Acting Drugs
        • Centrally Acting Drugs
        • BrazilAnti-Obesity Medication Market, By Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Others
      • Mexico
        • Mexico Anti-Obesity Medication Market, By Product
          • Approved
            • Bupropion-naltrexone (Contrave)
            • Liraglutide (Orlistat)
            • Orlistat
              • Xenical
              • Alli
            • Phentermine-topiramate (Qsymia)
            • Semaglutide (Wegovy)
            • Setmelanotide (Imcivree)
            • Tirzepatide (Zepbound)
          • Off Label
            • Semaglutide (Xenical Alli)
            • Liraglutide (Semaglutide (Wegovy))
            • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
            • Others
        • Mexico Anti-Obesity Medication Market, By Mechanism of Action
        • Peripherally Acting Drugs
        • Centrally Acting Drugs
        • Mexico Anti-Obesity Medication Market, By Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Others
      • Argentina
        • Argentina Anti-Obesity Medication Market, By Product
          • Approved
            • Bupropion-naltrexone (Contrave)
            • Liraglutide (Orlistat)
            • Orlistat
              • Xenical
              • Alli
            • Phentermine-topiramate (Qsymia)
            • Semaglutide (Wegovy)
            • Setmelanotide (Imcivree)
            • Tirzepatide (Zepbound)
          • Off Label
            • Semaglutide (Xenical Alli)
            • Liraglutide (Semaglutide (Wegovy))
            • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
            • Others
        • ArgentinaAnti-Obesity Medication Market, By Mechanism of Action
        • Peripherally Acting Drugs
        • Centrally Acting Drugs
        • ArgentinaAnti-Obesity Medication Market, By Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Others
    • MEA
      • MEA Anti-Obesity Medication Market, By Product
        • Approved
          • Bupropion-naltrexone (Contrave)
          • Liraglutide (Orlistat)
          • Orlistat
            • Xenical
            • Alli
          • Phentermine-topiramate (Qsymia)
          • Semaglutide (Wegovy)
          • Setmelanotide (Imcivree)
          • Tirzepatide (Zepbound)
        • Off Label
          • Semaglutide (Xenical Alli)
          • Liraglutide (Semaglutide (Wegovy))
          • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
          • Others
      • MEA Anti-Obesity Medication Market, By Mechanism of Action
      • Peripherally Acting Drugs
      • Centrally Acting Drugs
      • MEA Anti-Obesity Medication Market, By Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • Others
      • South Africa
        • South Africa Anti-Obesity Medication Market, By Product
          • Approved
            • Bupropion-naltrexone (Contrave)
            • Liraglutide (Orlistat)
            • Orlistat
              • Xenical
              • Alli
            • Phentermine-topiramate (Qsymia)
            • Semaglutide (Wegovy)
            • Setmelanotide (Imcivree)
            • Tirzepatide (Zepbound)
          • Off Label
            • Semaglutide (Xenical Alli)
            • Liraglutide (Semaglutide (Wegovy))
            • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
            • Others
        • South Africa Anti-Obesity Medication Market, By Mechanism of Action
        • Peripherally Acting Drugs
        • Centrally Acting Drugs
        • South Africa Anti-Obesity Medication Market, By Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Others
      • Saudi Arabia
        • Saudi Arabia Anti-Obesity Medication Market, By Product
          • Approved
            • Bupropion-naltrexone (Contrave)
            • Liraglutide (Orlistat)
            • Orlistat
              • Xenical
              • Alli
            • Phentermine-topiramate (Qsymia)
            • Semaglutide (Wegovy)
            • Setmelanotide (Imcivree)
            • Tirzepatide (Zepbound)
          • Off Label
            • Semaglutide (Xenical Alli)
            • Liraglutide (Semaglutide (Wegovy))
            • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
            • Others
        • Saudi Arabia Anti-Obesity Medication Market, By Mechanism of Action
        • Peripherally Acting Drugs
        • Centrally Acting Drugs
        • Saudi Arabia Anti-Obesity Medication Market, By Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Others
      • UAE
        • UAE Anti-Obesity Medication Market, By Product
          • Approved
            • Bupropion-naltrexone (Contrave)
            • Liraglutide (Orlistat)
            • Orlistat
              • Xenical
              • Alli
            • Phentermine-topiramate (Qsymia)
            • Semaglutide (Wegovy)
            • Setmelanotide (Imcivree)
            • Tirzepatide (Zepbound)
          • Off Label
            • Semaglutide (Xenical Alli)
            • Liraglutide (Semaglutide (Wegovy))
            • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
            • Others
        • UAE Anti-Obesity Medication Market, By Mechanism of Action
        • Peripherally Acting Drugs
        • Centrally Acting Drugs
        • UAE Anti-Obesity Medication Market, By Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Others
      • Kuwait
        • Kuwait Anti-Obesity Medication Market, By Product
          • Approved
            • Bupropion-naltrexone (Contrave)
            • Liraglutide (Orlistat)
            • Orlistat
              • Xenical
              • Alli
            • Phentermine-topiramate (Qsymia)
            • Semaglutide (Wegovy)
            • Setmelanotide (Imcivree)
            • Tirzepatide (Zepbound)
          • Off Label
            • Semaglutide (Xenical Alli)
            • Liraglutide (Semaglutide (Wegovy))
            • Dulaglutide (Trulicity) Topiramate (Dulaglutide (Trulicity))
            • Others
        • Kuwait Anti-Obesity Medication Market, By Mechanism of Action
        • Peripherally Acting Drugs
        • Centrally Acting Drugs
        • Kuwait Anti-Obesity Medication Market, By Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Other

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2018 to 2030
• Market estimates and forecast for product segments up to 2030
• Regional market size and forecast for product segments up to 2030
• Market estimates and forecast for application segments up to 2030
• Regional market size and forecast for application segments up to 2030
• Company financial performance